Mirae Asset Launches Maiden US Life Sciences Fund
31 Jan 2024
US$ 19.00
Mirae Asset Capital Life Science Inc (MACLS), the US-based life sciences-focused venture capital firm of South Korea’s M...
Related Publications
International Finance Corp is planning to invest up to US$150 m in a special situation fund, through a separately ......
Qiming Venture Partners (Qiming) has made a follow-on investment in the near Rmb100 m (US$14 m) series A funding ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.